SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-065891
Filing Date
2024-05-29
Accepted
2024-05-29 16:01:05
Documents
2
Period of Report
2024-05-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2213
2 EX-24 cogt-ex24.htm EX-24 10490
  Complete submission text file 0000950170-24-065891.txt   14357
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COGENT BIOSCIENCES, INC. 275 WYMAN STREET, 3RD FLOOR WALTHAM MA 02451
Business Address
Pinnow Cole (Reporting) CIK: 0002024135 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 24998220